I think UNVC will be in charge of Merck's prescrip
Post# of 85528
All IMO, but it's not that far of a stretch to see this scenario has great benefit to both companies. Regardless if this comes to fruition or not, we absolutely know UNVC will be working with Merck in some capacity. Just that is huge enough. Then consider the Mylan/Pfizer involvement. Another open door to a giant pharmi company.
Just a side note, the Nasdaq pharmaceutical sector is one of the most volatile segments of the entire stock market. With all the drug trials, approvals, rejections, new discoveries, etc......it's see some big swings.